Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

31.28
Delayed Data
As of Aug 31
 -0.39 / -1.23%
Today’s Change
29.50
Today|||52-Week Range
37.97
-11.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues6.6B6.4B5.7B6.2B
 
 
 
 
 
Cost of Goods Sold518.7M582.1M353.0M287.2M
 
 
 
 
 
Depreciation And Amortization855.4M972.8M794.8M701.8M
 
 
 
 
 
 
Operating ExpensesGross Income5.2B4.8B4.5B5.2B
 
 
 
 
 
General Expenses4.4B5.0B3.8B4.3B
 
 
 
 
 
Other Operating Expenses-0.000.0058.0M60.8M
 
 
 
 
Research And Development1.3B1.2B1.2B1.4B
 
 
 
 
 
Total Operating Expenses5.8B6.5B5.0B5.3B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income754.9M-159.1M661.9M879.3M
 
 
 
 
 
Extraordinary Charge-397.1M-372.5M-199.4M-230.4M
 
 
 
 
 
Interest Expense On Debt237.2M247.7M244.4M270.5M
 
 
 
 
 
Equity In Earnings-2.0M-3.8M-4.7M-2.0M
 
 
 
 
 
Other Expenses205.1M230.6M421.3M268.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income325.7M-548.8M639.4M646.9M
 
 
 
 
 
Income Taxes-69.4M-246.8M-118.0M-37.2M
 
 
 
 
 
Minority Interest-1.0M0.00-1.9M-980.2K
 
 
 
 
Net Income255.3M-305.8M514.9M683.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.6B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.10-$0.12$0.21$0.27
 
 
 
 
 
EPS Diluted$0.10-$0.12$0.20$0.27